Table 1 Open in new tab Clinical...

Patient	Sex	Age, years	Baseline heart disease	LVEF, %	NYHA functional class	Target arrhythmias	Electrical storm	Drugs failing to control arrhythmias	Specific HF Treatment before and during RFCA Session	Complete VT/VF Suppression after the last RFCA	Discharged Alive
1	Female	84	Previous MI	23	3	Monomorphic VT	Yes	AMD, Class Ib, BBL					Yes	Yes
2	Male	73	Previous and acute MI	34	4	Monomorphic VT	Yes	Class Ib	Yes	Yes	Yes	Yes	Yes	No
3	Female	72	Previous MI	24	3	Monomorphic VT	Yes	AMD, Class Ib					Yes	Yes
4	Female	51	NIDCM	16	3	Monomorphic VT		AMD					Yes	Yes
5	Male	74	Previous MI	25	4	PVC triggering VF	Yes	AMD, Class Ib		Yes			Yes	Yes
6	Male	73	Dilated HCM	30	4	Three monomorphic VTs	Yes	AMD, NIF, BBL		Yes			No	Yes
7	Male	71	Previous and acute MI	25	4	PVC triggering VF	Yes	AMD, NIF, Class Ib, BBL	Yes	Yes		Yes	Yes	No
8	Male	55	Dilated HCM	35	4	Monomorphic VT	Yes	AMD, NIF, BBL	Yes	Yes			No	Yes
9	Female	83	Previous MI	36	3	PVC triggering VF	Yes	AMD, BBL					Yes	Yes
10	Male	67	Acute MI	36	4	PVC triggering VF	Yes	AMD, Class Ib, BBL	Yes	Yes	Yes	Yes	Yes	Yes
						Monomorphic VT
11	Male	75	NIDCM	20	3	Two monomorphic VTs	Yes	AMD, NIF, BBL					No	Yes
12	Male	69	Previous MI	25	3	Monomorphic VT	Yes	AMD, NIF, BBL					Yes	Yes
13	Male	68	NIDCM	10	3	Two monomorphic VTs		AMD, BBL			Yes		Yes	Yes
14	Male	57	Acute MI	15	4	PVC triggering VF		AMD, Class Ib, BBL	Yes	Yes	Yes	Yes	Yes	No
15	Male	66	Previous MI	29	4	Monomorphic VT	Yes	AMD, Class Ib, BBL			Yes		Yes	Yes

Patient

Sex

Age, years

Baseline heart disease

LVEF, %

NYHA functional class

Target arrhythmias

Electrical storm

Drugs failing to control arrhythmias

Specific HF Treatment before and during RFCA Session

Complete VT/VF Suppression after the last RFCA

Discharged Alive

Intravenous catecholamine

Mechanical ventilation

IABP

CHDF

Female

Previous MI

Monomorphic VT

Yes

AMD, Class Ib, BBL

Yes

Male

Previous and acute MI

Monomorphic VT

Yes

Class Ib

Yes

Female

Previous MI

Monomorphic VT

Yes

AMD, Class Ib

Yes

Female

NIDCM

Monomorphic VT

AMD

Yes

Male

Previous MI

PVC triggering VF

Yes

AMD, Class Ib

Yes

Male

Dilated HCM

Three monomorphic VTs

Yes

AMD, NIF, BBL

Yes

Male

Previous and acute MI

PVC triggering VF

Yes

AMD, NIF, Class Ib, BBL

Yes

Male

Dilated HCM

Monomorphic VT

Yes

AMD, NIF, BBL

Yes

Female

Previous MI

PVC triggering VF

Yes

AMD, BBL

Yes

Male

Acute MI

PVC triggering VF

Yes

AMD, Class Ib, BBL

Yes

Monomorphic VT

Male

NIDCM

Two monomorphic VTs

Yes

AMD, NIF, BBL

Yes

Male

Previous MI

Monomorphic VT

Yes

AMD, NIF, BBL

Yes

Male

NIDCM

Two monomorphic VTs

AMD, BBL

Yes

Male

Acute MI

PVC triggering VF

AMD, Class Ib, BBL

Yes

Male

Previous MI

Monomorphic VT

Yes

AMD, Class Ib, BBL

Yes

Patient	Sex	Age, years	Baseline heart disease	LVEF, %	NYHA functional class	Target arrhythmias	Electrical storm	Drugs failing to control arrhythmias	Specific HF Treatment before and during RFCA Session	Complete VT/VF Suppression after the last RFCA	Discharged Alive
1	Female	84	Previous MI	23	3	Monomorphic VT	Yes	AMD, Class Ib, BBL					Yes	Yes
2	Male	73	Previous and acute MI	34	4	Monomorphic VT	Yes	Class Ib	Yes	Yes	Yes	Yes	Yes	No
3	Female	72	Previous MI	24	3	Monomorphic VT	Yes	AMD, Class Ib					Yes	Yes
4	Female	51	NIDCM	16	3	Monomorphic VT		AMD					Yes	Yes
5	Male	74	Previous MI	25	4	PVC triggering VF	Yes	AMD, Class Ib		Yes			Yes	Yes
6	Male	73	Dilated HCM	30	4	Three monomorphic VTs	Yes	AMD, NIF, BBL		Yes			No	Yes
7	Male	71	Previous and acute MI	25	4	PVC triggering VF	Yes	AMD, NIF, Class Ib, BBL	Yes	Yes		Yes	Yes	No
8	Male	55	Dilated HCM	35	4	Monomorphic VT	Yes	AMD, NIF, BBL	Yes	Yes			No	Yes
9	Female	83	Previous MI	36	3	PVC triggering VF	Yes	AMD, BBL					Yes	Yes
10	Male	67	Acute MI	36	4	PVC triggering VF	Yes	AMD, Class Ib, BBL	Yes	Yes	Yes	Yes	Yes	Yes
						Monomorphic VT
11	Male	75	NIDCM	20	3	Two monomorphic VTs	Yes	AMD, NIF, BBL					No	Yes
12	Male	69	Previous MI	25	3	Monomorphic VT	Yes	AMD, NIF, BBL					Yes	Yes
13	Male	68	NIDCM	10	3	Two monomorphic VTs		AMD, BBL			Yes		Yes	Yes
14	Male	57	Acute MI	15	4	PVC triggering VF		AMD, Class Ib, BBL	Yes	Yes	Yes	Yes	Yes	No
15	Male	66	Previous MI	29	4	Monomorphic VT	Yes	AMD, Class Ib, BBL			Yes		Yes	Yes

Table 1

Open in new tab

Clinical characteristics of the study population

Patient	Sex	Age, years	Baseline heart disease	LVEF, %	NYHA functional class	Target arrhythmias	Electrical storm	Drugs failing to control arrhythmias	Specific HF Treatment before and during RFCA Session				Complete VT/VF Suppression after the last RFCA	Discharged Alive
Patient	Sex	Age, years	Baseline heart disease	LVEF, %	NYHA functional class	Target arrhythmias	Electrical storm	Drugs failing to control arrhythmias	Intravenous catecholamine	Mechanical ventilation	IABP	CHDF	Complete VT/VF Suppression after the last RFCA
1	Female	84	Previous MI	23	3	Monomorphic VT	Yes	AMD, Class Ib, BBL					Yes	Yes
2	Male	73	Previous and acute MI	34	4	Monomorphic VT	Yes	Class Ib	Yes	Yes	Yes	Yes	Yes	No
3	Female	72	Previous MI	24	3	Monomorphic VT	Yes	AMD, Class Ib					Yes	Yes
4	Female	51	NIDCM	16	3	Monomorphic VT		AMD					Yes	Yes
5	Male	74	Previous MI	25	4	PVC triggering VF	Yes	AMD, Class Ib		Yes			Yes	Yes
6	Male	73	Dilated HCM	30	4	Three monomorphic VTs	Yes	AMD, NIF, BBL		Yes			No	Yes
7	Male	71	Previous and acute MI	25	4	PVC triggering VF	Yes	AMD, NIF, Class Ib, BBL	Yes	Yes		Yes	Yes	No
8	Male	55	Dilated HCM	35	4	Monomorphic VT	Yes	AMD, NIF, BBL	Yes	Yes			No	Yes
9	Female	83	Previous MI	36	3	PVC triggering VF	Yes	AMD, BBL					Yes	Yes
10	Male	67	Acute MI	36	4	PVC triggering VF	Yes	AMD, Class Ib, BBL	Yes	Yes	Yes	Yes	Yes	Yes
						Monomorphic VT
11	Male	75	NIDCM	20	3	Two monomorphic VTs	Yes	AMD, NIF, BBL					No	Yes
12	Male	69	Previous MI	25	3	Monomorphic VT	Yes	AMD, NIF, BBL					Yes	Yes
13	Male	68	NIDCM	10	3	Two monomorphic VTs		AMD, BBL			Yes		Yes	Yes
14	Male	57	Acute MI	15	4	PVC triggering VF		AMD, Class Ib, BBL	Yes	Yes	Yes	Yes	Yes	No
15	Male	66	Previous MI	29	4	Monomorphic VT	Yes	AMD, Class Ib, BBL			Yes		Yes	Yes

Patient	Sex	Age, years	Baseline heart disease	LVEF, %	NYHA functional class	Target arrhythmias	Electrical storm	Drugs failing to control arrhythmias	Specific HF Treatment before and during RFCA Session				Complete VT/VF Suppression after the last RFCA	Discharged Alive
Patient	Sex	Age, years	Baseline heart disease	LVEF, %	NYHA functional class	Target arrhythmias	Electrical storm	Drugs failing to control arrhythmias	Intravenous catecholamine	Mechanical ventilation	IABP	CHDF	Complete VT/VF Suppression after the last RFCA
1	Female	84	Previous MI	23	3	Monomorphic VT	Yes	AMD, Class Ib, BBL					Yes	Yes
2	Male	73	Previous and acute MI	34	4	Monomorphic VT	Yes	Class Ib	Yes	Yes	Yes	Yes	Yes	No
3	Female	72	Previous MI	24	3	Monomorphic VT	Yes	AMD, Class Ib					Yes	Yes
4	Female	51	NIDCM	16	3	Monomorphic VT		AMD					Yes	Yes
5	Male	74	Previous MI	25	4	PVC triggering VF	Yes	AMD, Class Ib		Yes			Yes	Yes
6	Male	73	Dilated HCM	30	4	Three monomorphic VTs	Yes	AMD, NIF, BBL		Yes			No	Yes
7	Male	71	Previous and acute MI	25	4	PVC triggering VF	Yes	AMD, NIF, Class Ib, BBL	Yes	Yes		Yes	Yes	No
8	Male	55	Dilated HCM	35	4	Monomorphic VT	Yes	AMD, NIF, BBL	Yes	Yes			No	Yes
9	Female	83	Previous MI	36	3	PVC triggering VF	Yes	AMD, BBL					Yes	Yes
10	Male	67	Acute MI	36	4	PVC triggering VF	Yes	AMD, Class Ib, BBL	Yes	Yes	Yes	Yes	Yes	Yes
						Monomorphic VT
11	Male	75	NIDCM	20	3	Two monomorphic VTs	Yes	AMD, NIF, BBL					No	Yes
12	Male	69	Previous MI	25	3	Monomorphic VT	Yes	AMD, NIF, BBL					Yes	Yes
13	Male	68	NIDCM	10	3	Two monomorphic VTs		AMD, BBL			Yes		Yes	Yes
14	Male	57	Acute MI	15	4	PVC triggering VF		AMD, Class Ib, BBL	Yes	Yes	Yes	Yes	Yes	No
15	Male	66	Previous MI	29	4	Monomorphic VT	Yes	AMD, Class Ib, BBL			Yes		Yes	Yes

AMD, amiodarone; BBL, beta-blocker; CHDF, continuous haemodiafiltration; HCM, hypertrophic cardiomyopathy; HF, heart failure; IABP, intra-aortic balloon counterpulsation; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NIDCM, non-ischaemic dilated cardiomyopathy; NIF, nifekalant; NYHA, New York Heart Association; RFCA, radiofrequency catheter ablation; VF, ventricular fibrillation; VT, ventricular tachycardia.

This Feature Is Available To Subscribers Only